(1 - 14 von 16
)
A Step Ahead of Cancer Cells. Important Insights Into Resistance...
www.inar.de
Always one step ahead of cancer cells BRD4 inhibitors are among the most promising new agents in cancer therapy that are currently evaluated in clinical
Always one step ahead of cancer cells
www.bionity.com
BRD4 inhibitors are among the most promising new agents in cancer therapy that are currently evaluated in clinical trials. A team of researchers at the...
Epigenetic study provides new approaches to Medical Xpressmedicalxpress.com › Genetics
medicalxpress.com
· Sara Sdelci: "Philipp Rathert had generated data showing that MTHFD1 also physically binds to BRD4." In subsequent experiments, she showed that ...
CeMM: Epigenetische Studie liefert neue Ansätze für ...
www.lisavienna.at
— Bei einer Konferenz traf sie Philipp Rathert aus Johannes Zuber's Labor am IMP, an dem auch zu BRD4 geforscht wird. › news › cemm-epigenetische-...
sortiert nach Relevanz / Datum